Cargando…
Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [(18)F]flortaucipir study
Cortical tau accumulation is a key pathological event that partly defines Alzheimer’s disease (AD) onset and is associated with cognitive decline and future disease progression. However, an improved understanding of the timing and pattern of early tau deposition in AD and how this may be tracked in...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210376/ https://www.ncbi.nlm.nih.gov/pubmed/37231491 http://dx.doi.org/10.1186/s13195-023-01234-5 |
_version_ | 1785047054426308608 |
---|---|
author | O’Connor, Antoinette Cash, David M. Poole, Teresa Markiewicz, Pawel J. Fraser, Maggie R. Malone, Ian B. Jiao, Jieqing Weston, Philip S. J. Flores, Shaney Hornbeck, Russ McDade, Eric Schöll, Michael Gordon, Brian A. Bateman, Randall J. Benzinger, Tammie L. S. Fox, Nick C. |
author_facet | O’Connor, Antoinette Cash, David M. Poole, Teresa Markiewicz, Pawel J. Fraser, Maggie R. Malone, Ian B. Jiao, Jieqing Weston, Philip S. J. Flores, Shaney Hornbeck, Russ McDade, Eric Schöll, Michael Gordon, Brian A. Bateman, Randall J. Benzinger, Tammie L. S. Fox, Nick C. |
author_sort | O’Connor, Antoinette |
collection | PubMed |
description | Cortical tau accumulation is a key pathological event that partly defines Alzheimer’s disease (AD) onset and is associated with cognitive decline and future disease progression. However, an improved understanding of the timing and pattern of early tau deposition in AD and how this may be tracked in vivo is needed. Data from 59 participants involved in two longitudinal cohort studies of autosomal dominant AD (ADAD) were used to investigate whether tau PET can detect and track presymptomatic change; seven participants were symptomatic, and 52 were asymptomatic but at a 50% risk of carrying a pathogenic mutation. All had baseline flortaucipir (FTP) PET, MRI and clinical assessments; 26 individuals had more than one FTP PET scan. Standardised uptake value ratios (SUVRs) in prespecified regions of interest (ROIs) were obtained using inferior cerebellar grey matter as the reference region. We compared the changes in FTP SUVRs between presymptomatic carriers, symptomatic carriers and non-carriers, adjusting for age, sex and study site. We also investigated the relationship between regional FTP SUVRs and estimated years to/from symptom onset (EYO). Compared to both non-carriers and presymptomatic carriers, FTP SUVRs were significantly higher in symptomatic carriers in all ROIs tested (p < 0.001). There were no significant regional differences between presymptomatic carriers and non-carriers in FTP SUVRs, or their rates of change (p > 0.05), although increased FTP signal uptake was seen posteriorly in some individuals around the time of expected symptom onset. When we examined the relationship of FTP SUVR with respect to EYO, the earliest significant regional difference between mutation carriers and non-carriers was detected within the precuneus prior to estimated symptom onset in some cases. This study supports preliminary studies suggesting that presymptomatic tau tracer uptake is rare in ADAD. In cases where early uptake was seen, there was often a predilection for posterior regions (the precuneus and post-cingulate) as opposed to the medial temporal lobe, highlighting the importance of examining in vivo tau uptake beyond the confines of traditional Braak staging. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01234-5. |
format | Online Article Text |
id | pubmed-10210376 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102103762023-05-26 Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [(18)F]flortaucipir study O’Connor, Antoinette Cash, David M. Poole, Teresa Markiewicz, Pawel J. Fraser, Maggie R. Malone, Ian B. Jiao, Jieqing Weston, Philip S. J. Flores, Shaney Hornbeck, Russ McDade, Eric Schöll, Michael Gordon, Brian A. Bateman, Randall J. Benzinger, Tammie L. S. Fox, Nick C. Alzheimers Res Ther Research Cortical tau accumulation is a key pathological event that partly defines Alzheimer’s disease (AD) onset and is associated with cognitive decline and future disease progression. However, an improved understanding of the timing and pattern of early tau deposition in AD and how this may be tracked in vivo is needed. Data from 59 participants involved in two longitudinal cohort studies of autosomal dominant AD (ADAD) were used to investigate whether tau PET can detect and track presymptomatic change; seven participants were symptomatic, and 52 were asymptomatic but at a 50% risk of carrying a pathogenic mutation. All had baseline flortaucipir (FTP) PET, MRI and clinical assessments; 26 individuals had more than one FTP PET scan. Standardised uptake value ratios (SUVRs) in prespecified regions of interest (ROIs) were obtained using inferior cerebellar grey matter as the reference region. We compared the changes in FTP SUVRs between presymptomatic carriers, symptomatic carriers and non-carriers, adjusting for age, sex and study site. We also investigated the relationship between regional FTP SUVRs and estimated years to/from symptom onset (EYO). Compared to both non-carriers and presymptomatic carriers, FTP SUVRs were significantly higher in symptomatic carriers in all ROIs tested (p < 0.001). There were no significant regional differences between presymptomatic carriers and non-carriers in FTP SUVRs, or their rates of change (p > 0.05), although increased FTP signal uptake was seen posteriorly in some individuals around the time of expected symptom onset. When we examined the relationship of FTP SUVR with respect to EYO, the earliest significant regional difference between mutation carriers and non-carriers was detected within the precuneus prior to estimated symptom onset in some cases. This study supports preliminary studies suggesting that presymptomatic tau tracer uptake is rare in ADAD. In cases where early uptake was seen, there was often a predilection for posterior regions (the precuneus and post-cingulate) as opposed to the medial temporal lobe, highlighting the importance of examining in vivo tau uptake beyond the confines of traditional Braak staging. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01234-5. BioMed Central 2023-05-25 /pmc/articles/PMC10210376/ /pubmed/37231491 http://dx.doi.org/10.1186/s13195-023-01234-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research O’Connor, Antoinette Cash, David M. Poole, Teresa Markiewicz, Pawel J. Fraser, Maggie R. Malone, Ian B. Jiao, Jieqing Weston, Philip S. J. Flores, Shaney Hornbeck, Russ McDade, Eric Schöll, Michael Gordon, Brian A. Bateman, Randall J. Benzinger, Tammie L. S. Fox, Nick C. Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [(18)F]flortaucipir study |
title | Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [(18)F]flortaucipir study |
title_full | Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [(18)F]flortaucipir study |
title_fullStr | Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [(18)F]flortaucipir study |
title_full_unstemmed | Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [(18)F]flortaucipir study |
title_short | Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [(18)F]flortaucipir study |
title_sort | tau accumulation in autosomal dominant alzheimer’s disease: a longitudinal [(18)f]flortaucipir study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210376/ https://www.ncbi.nlm.nih.gov/pubmed/37231491 http://dx.doi.org/10.1186/s13195-023-01234-5 |
work_keys_str_mv | AT oconnorantoinette tauaccumulationinautosomaldominantalzheimersdiseasealongitudinal18fflortaucipirstudy AT cashdavidm tauaccumulationinautosomaldominantalzheimersdiseasealongitudinal18fflortaucipirstudy AT pooleteresa tauaccumulationinautosomaldominantalzheimersdiseasealongitudinal18fflortaucipirstudy AT markiewiczpawelj tauaccumulationinautosomaldominantalzheimersdiseasealongitudinal18fflortaucipirstudy AT frasermaggier tauaccumulationinautosomaldominantalzheimersdiseasealongitudinal18fflortaucipirstudy AT maloneianb tauaccumulationinautosomaldominantalzheimersdiseasealongitudinal18fflortaucipirstudy AT jiaojieqing tauaccumulationinautosomaldominantalzheimersdiseasealongitudinal18fflortaucipirstudy AT westonphilipsj tauaccumulationinautosomaldominantalzheimersdiseasealongitudinal18fflortaucipirstudy AT floresshaney tauaccumulationinautosomaldominantalzheimersdiseasealongitudinal18fflortaucipirstudy AT hornbeckruss tauaccumulationinautosomaldominantalzheimersdiseasealongitudinal18fflortaucipirstudy AT mcdadeeric tauaccumulationinautosomaldominantalzheimersdiseasealongitudinal18fflortaucipirstudy AT schollmichael tauaccumulationinautosomaldominantalzheimersdiseasealongitudinal18fflortaucipirstudy AT gordonbriana tauaccumulationinautosomaldominantalzheimersdiseasealongitudinal18fflortaucipirstudy AT batemanrandallj tauaccumulationinautosomaldominantalzheimersdiseasealongitudinal18fflortaucipirstudy AT benzingertammiels tauaccumulationinautosomaldominantalzheimersdiseasealongitudinal18fflortaucipirstudy AT foxnickc tauaccumulationinautosomaldominantalzheimersdiseasealongitudinal18fflortaucipirstudy |